Latest filings (excl ownership)
15-12B
Securities registration termination
2 Dec 21
8-K
Completion of Acquisition or Disposition of Assets
22 Nov 21
25-NSE
Exchange delisting
22 Nov 21
SC 14D9/A
Tender offer solicitation (amended)
22 Nov 21
SC TO-T/A
Third party tender offer statement (amended)
22 Nov 21
SC 14D9/A
Tender offer solicitation (amended)
17 Nov 21
SC TO-T/A
Third party tender offer statement (amended)
17 Nov 21
SC 14D9/A
Tender offer solicitation (amended)
17 Nov 21
SC 14D9/A
Tender offer solicitation (amended)
12 Nov 21
SC 14D9/A
Tender offer solicitation (amended)
10 Nov 21
SC TO-T/A
Third party tender offer statement (amended)
8 Nov 21
SC 14D9/A
Tender offer solicitation (amended)
8 Nov 21
10-Q
2021 Q3
Quarterly report
4 Nov 21
8-K
Acceleron Reports Third Quarter 2021 Financial Results
4 Nov 21
SC TO-T/A
Third party tender offer statement (amended)
29 Oct 21
SC 14D9/A
Tender offer solicitation (amended)
29 Oct 21
SC 14D9
Tender offer solicitation
28 Oct 21
8-K
Results of Operations and Financial Condition
27 Oct 21
SC 14D9
Tender offer solicitation
20 Oct 21
SC 14D9
Tender offer solicitation
13 Oct 21
SC 14D9
Tender offer solicitation
12 Oct 21
SC TO-T
Third party tender offer statement
12 Oct 21
SC TO-C
Information about tender offer
1 Oct 21
SC TO-C
Information about tender offer
30 Sep 21
SC14D9C
Written communication relating to third party tender offer
30 Sep 21
SC14D9C
Written communication relating to third party tender offer
30 Sep 21
8-K
Entry into a Material Definitive Agreement
30 Sep 21
10-Q
2021 Q2
Quarterly report
5 Aug 21
8-K
Acceleron Reports Second Quarter 2021 Financial Results
5 Aug 21
8-K
Results of Operations and Financial Condition
28 Jul 21
8-K
Regulation FD Disclosure
22 Jun 21
8-K
Submission of Matters to a Vote of Security Holders
21 Jun 21
8-K
Bristol Myers Squibb and Acceleron Present First Results from Phase 2
17 Jun 21
8-K
Other Events
19 May 21
10-Q
2021 Q1
Quarterly report
6 May 21
8-K
Acceleron Reports First Quarter 2021 Financial Results
6 May 21
8-K
Results of Operations and Financial Condition
29 Apr 21
DEFA14A
Additional proxy soliciting materials
22 Apr 21
DEF 14A
Definitive proxy
22 Apr 21
8-K
Other Events
5 Apr 21
Latest ownership filings
SC 13D/A
Avoro Capital Advisors LLC
24 Nov 21
4
Joseph S Zakrzewski
22 Nov 21
4
Kemal Malik
22 Nov 21
4
Christopher Hite
22 Nov 21
4
Karen L. Smith
22 Nov 21
4
Thomas A MCCOURT
22 Nov 21
4
Terrence C Kearney
22 Nov 21
4
Laura Hamill
22 Nov 21
4
Francois Nader
22 Nov 21
4
Adam M Veness
22 Nov 21
4
SUJAY KANGO
22 Nov 21
4
Jay T. Backstrom
22 Nov 21
4
KEVIN F MCLAUGHLIN
22 Nov 21
4
Habib J Dable
22 Nov 21
4
Adam M Veness
12 Nov 21
SC 13G/A
FMR LLC
10 Nov 21
SC 13D
Avoro Capital Advisors LLC
5 Oct 21
4
SUJAY KANGO
27 Sep 21
4
KEVIN F MCLAUGHLIN
24 Sep 21
4
Adam M Veness
22 Sep 21
4
SUJAY KANGO
22 Sep 21
4
Adam M Veness
9 Sep 21
4
Habib J Dable
2 Jul 21
4
Adam M Veness
8 Jun 21
4
SUJAY KANGO
8 Jun 21
4
Thomas A MCCOURT
21 Apr 21
4
Joseph S Zakrzewski
5 Apr 21
4
Karen L. Smith
5 Apr 21
4
Joseph S Zakrzewski
2 Apr 21
4
Karen L. Smith
2 Apr 21
4
SUJAY KANGO
4 Mar 21
SC 13G/A
PRICE T ROWE ASSOCIATES INC /MD/
16 Feb 21
SC 13G/A
VANGUARD GROUP INC
10 Feb 21
SC 13G/A
FMR LLC
8 Feb 21
4
Adam M Veness
2 Feb 21
4
KEVIN F MCLAUGHLIN
2 Feb 21
4
SUJAY KANGO
2 Feb 21
4/A
SUJAY KANGO
2 Feb 21
4
Jay T. Backstrom
2 Feb 21
4
Habib J Dable
2 Feb 21